Kyowa Kirin Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3256000005
JPY
2,527.50
17.5 (0.7%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Astellas Pharma, Inc.
Chugai Pharmaceutical Co., Ltd.
Shionogi & Co., Ltd.
Otsuka Holdings Co., Ltd.
Ono Pharmaceutical Co., Ltd.
Daiichi Sankyo Co., Ltd.
Eisai Co., Ltd.
Kyowa Kirin Co., Ltd.
Takeda Pharmaceutical Co., Ltd.
Kobayashi Pharmaceutical Co., Ltd.
Taisho Pharmaceutical Holdings Co., Ltd.
Why is Kyowa Kirin Co., Ltd. ?
1
Company has very low debt and has enough cash to service the debt requirements
2
Low Debt Company with Strong Long Term Fundamental Strength
3
The company has declared Negative results for the last 3 consecutive quarters
  • OPERATING CASH FLOW(Y) Lowest at JPY 60,873 MM
  • ROCE(HY) Lowest at 4.51%
  • INTEREST(Q) At JPY 2,539 MM has Grown at 1,700.71%
4
With ROE of 6.08%, it has a very attractive valuation with a 1.56 Price to Book Value
  • The stock is trading at a premium compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 1.10%, its profits have fallen by -43.2%
  • At the current price, the company has a high dividend yield of 0
5
Underperformed the market in the last 1 year
  • The stock has generated a return of 1.10% in the last 1 year, much lower than market (Japan Nikkei 225) returns of 29.35%
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to Kyowa Kirin Co., Ltd. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Kyowa Kirin Co., Ltd. for you?

Low Risk, High Return

Absolute
Risk Adjusted
Volatility
Kyowa Kirin Co., Ltd.
1.79%
600.38
22.49%
Japan Nikkei 225
28.54%
1.14
25.81%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
9.99%
EBIT Growth (5y)
9.37%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.26
Sales to Capital Employed (avg)
0.55
Tax Ratio
30.50%
Dividend Payout Ratio
51.30%
Pledged Shares
0
Institutional Holding
0.16%
ROCE (avg)
16.11%
ROE (avg)
7.78%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
26
Industry P/E
Price to Book Value
1.56
EV to EBIT
12.74
EV to EBITDA
9.81
EV to Capital Employed
1.75
EV to Sales
2.19
PEG Ratio
NA
Dividend Yield
0.04%
ROCE (Latest)
13.76%
ROE (Latest)
6.08%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Sideways
Moving Averages
Bullish (Daily)
KST
Mildly Bullish
Mildly Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

3What is working for the Company
DIVIDEND PER SHARE(HY)

Highest at JPY 3.46

RAW MATERIAL COST(Y)

Fallen by 0.94% (YoY

-28What is not working for the Company
OPERATING CASH FLOW(Y)

Lowest at JPY 60,873 MM

ROCE(HY)

Lowest at 4.51%

INTEREST(Q)

At JPY 2,539 MM has Grown at 1,700.71%

PRE-TAX PROFIT(Q)

At JPY 11,655 MM has Fallen at -56.26%

NET PROFIT(Q)

At JPY 10,153 MM has Fallen at -56.78%

DEBT-EQUITY RATIO (HY)

Highest at -25.13 %

DEBTORS TURNOVER RATIO(HY)

Lowest at 3.46%

Here's what is working for Kyowa Kirin Co., Ltd.
Dividend per share
Highest at JPY 3.46 and Grown
In each year in the last five years
MOJO Watch
Company is distributing higher dividend from profits generated

DPS (JPY)

Raw Material Cost
Fallen by 0.94% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Kyowa Kirin Co., Ltd.
Interest
At JPY 2,539 MM has Grown at 1,700.71%
period on period (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (JPY MM)

Pre-Tax Profit
At JPY 11,655 MM has Fallen at -56.26%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (JPY MM)

Net Profit
At JPY 10,153 MM has Fallen at -56.78%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (JPY MM)

Operating Cash Flow
Lowest at JPY 60,873 MM
in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (JPY MM)

Debt-Equity Ratio
Highest at -25.13 %
in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Debtors Turnover Ratio
Lowest at 3.46%
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio